Objectives: To assess whether microemboli burden, assessed noninvasively by bedside transcranial Doppler ultrasonography, correlates with risk of subsequent stroke greater than 24 hours after hospital arrival among patients with blunt cerebrovascular injury. The greater than 24-hour time frame provides a window for transcranial Doppler examinations and therapeutic interventions to prevent stroke.
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Transcranial Doppler Microemboli Monitoring for Stroke Risk Stratification in Blunt Cerebrovascular Injury
Robert H. Bonow, MD 1, 2 ; Cordelie E. Witt, MD 1, 3 ; Bryan P. Mosher, PhD 4 ; Mahmud Mossa-Basha, MD 1, 5 ; Monica S. Vavilala, MD 1, 6 ; Frederick P. Rivara, MD, MPH 1, 7 ; Joseph Cuschieri, MD 1, 3 screening protocols in patients at risk for blunt cerebrovascular injury (BCVI) has enabled detection of asymptomatic injuries and has therefore provided an opportunity to prevent stroke (3, (6) (7) (8) . Still, there is debate regarding optimal medical therapy to mitigate stroke risk following BCVI diagnosis. Both preventative anticoagulation (6, (9) (10) (11) (12) and antiplatelet therapy (4, 5, 8, (13) (14) (15) (16) have been advocated, but there are no data to support the superiority of either approach.
At our institution, we routinely employ transcranial Doppler (TCD) microemboli monitoring, which is a safe, noninvasive, bedside ultrasonography test that may enable stroke risk stratification. The presence of microemboli on TCD examinations is associated with stroke in atrial fibrillation, atherosclerotic carotid stenosis, nontraumatic dissections, and in patients undergoing surgery (17) (18) (19) (20) (21) (22) . TCDs are routinely performed during stroke workup at some centers. In BCVI, our group has previously shown that individuals with microemboli distal to a traumatic carotid pseudoaneurysm or occlusion were more likely to have suffered a stroke, although the timing of stroke relative to the TCD examination was not considered (14, 15) .
It remains unknown that how well TCD microemboli monitoring predicts the risk of subsequent stroke in BCVI. Furthermore, earlier studies have not examined TCD findings in lower grade injuries, which are more common than highgrade injuries (23) . If the probability of stroke can be predicted, aggressive interventions may be targeted selectively to those at greatest risk.
MATERIALS AND METHODS

Patient Selection and Data Collection
This was a retrospective cohort study performed at Harborview Medical Center, the only level I trauma center in Washington and a regional trauma referral center for Alaska, Montana, and Idaho. This study was approved by the University of Washington Institutional Review Board, which waived the need for informed consent.
We included all adult and pediatric patients with BCVI treated at our center from April 1, 2005 , to June 30, 2015. Patients were identified from our institutional trauma registry and a separately maintained database of TCD examinations using International Classification of Diseases, Ninth Edition, Clinical Modification and Abbreviated Injury Scale codes for BCVI. Patients who died within 48 hours were excluded, as their degree of illness frequently limited our ability to detect BCVI and stroke.
Demographic, injury, clinical, radiology, TCD, and medication data were obtained from patients' medical records and our institutional trauma registry. Stroke presence was ascertained using the trauma registry, which uses prospective, manual assessment of in-hospital complications by trained reviewers in accordance with American College of Surgeons Trauma Quality Improvement Program criteria (24) . All patients with stroke underwent detailed chart review to confirm stroke occurrence, location, timing, progression (defined as discrete enlargement of initial stroke or new stroke in a distinct territory), and etiologies.
TCD Ultrasonography for BCVI TCD monitoring was performed over at least three once-daily examinations by a registered vascular technician using a Natus SONARA ultrasound machine (Natus Neurology, Middleton, WI) with a 2 MHz pulsed wave probe. For ICA injuries, monitoring was performed on the ipsilateral middle cerebral artery at 50 mm depth. For VA injuries, monitoring was performed on either the basilar artery at 90 mm depth or the bilateral posterior cerebral arteries at 60-70 mm depth, depending on bone windows and whether the patient required a cervical collar. Microembolic signals (MESs) were defined as greater than or equal to 3 dB above background intensity, lasting less than 0.1 second, randomly occurring, unidirectional, and causing a spike in the intensity trace. For each injured vessel, microemboli were counted during approximately 20-minute examinations (as permitted by clinical stability) and extrapolated to hourly rates. The relatively brief assessment time was chosen to minimize clinical disruption for these injured patients. The primary analysis used a binary assessment of TCDs as either positive (≥ one microembolus) or negative; a secondary analysis considered the hourly rate of microemboli. For patients with delayed BCVI stroke (as defined below), we considered only TCD examinations performed before stroke.
BCVI Grading
BCVI grade was assigned through manual review of radiology reports according to the Denver criteria: grade 1 for less than 25% luminal narrowing; grade 2 for greater than 25% luminal narrowing, intraluminal thrombus, or intimal flap; grade 3 for pseudoaneurysm; grade 4 for vessel occlusion; and grade 5 for vessel transection and/or active extravasation (23) . When radiology records were insufficient to assign injury grade, images were reviewed by a board-certified neuroradiologist blinded to clinical data (M.M.B.).
BCVI-Related Stroke
BCVI-related strokes were those that occurred in the vascular distribution of the injured vessel and were not definitively determined to be due to pre-existing cerebrovascular disease, global hypoxia/hypoperfusion (e.g., following cardiac event, drowning, hypotensive event, and strangulation), paradoxical embolism, vasospastic process, cardiac arrhythmia, venous infarction, neurosurgical intervention, direct trauma, or herniation syndrome (flowchart available in Supplemental Fig. 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/ C681). Etiologic determination was based on directed workup and assessment by the inpatient teams at our Level I Stroke Center. The primary outcome was new BCVI-related stroke, or documented progression of a stroke, detected more than 24 hours after arrival. The 24-hour cutoff provides time to perform TCD examinations and make therapeutic changes to prevent stroke and allowed us to focus on potentially preventable strokes definitively occurring subsequent to TCD examinations.
Medication Use
Our institutional approach is to initiate aspirin immediately upon BCVI diagnosis. For patients at risk for hemorrhagic complications from concomitant injuries, therapy is initiated upon stabilization of imaging studies and hemodynamic trends. Patients deemed at high risk of stroke based on imaging characteristics or TCD examinations are escalated to more aggressive therapy as permitted by other injuries (14, 15) . For the present study, medication escalation was defined as a transition from aspirin to more aggressive regimens that included clopidogrel (e.g., dual antiplatelet therapy) or therapeutic anticoagulation. Medication use prior to stroke or in the first 15 days (corresponding to the latest stroke in our cohort) was assessed.
Data Analysis
Descriptive evaluations were performed, as were bivariable analyses assessing injury grade, medication administration, number of vessels injured, and TCD results, stratified by stroke status and injured vessel. Due to the large number of injury permutations with five grades of injury across four vessels and the possibility that concomitant vascular injuries may influence the risk of stroke, the primary analysis focused on patients with isolated vascular injuries. Multivariable analyses adjusting for injury grade were conducted using Poisson regression to estimate risk ratios (RRs). For the primary analyses focusing on isolated injuries, exact Poisson regression was used given the small number of strokes.
We also performed a secondary analysis of patients who sustained an ICA injury with or without concomitant ICA or VA injuries. Due to the complexity of analyzing all possible permutations of injury, this analysis was conducted at the level of the injured vessel with stroke in the ipsilateral hemisphere as the outcome. We used a Poisson regression with robust ses and adjusted for ipsilateral ICA injury grade and contralateral ICA injury grade (when present). This model was clustered at the level of the patient to account for the nonindependence of these observations. An analogous analysis was not performed for nonisolated VA injuries because both vessels supply largely the same vascular territory, and thus, posterior circulation strokes could not definitively be attributed to a single VA. Statistical analysis was performed using Stata/IC version 14 (StataCorp LP, College Station, TX).
RESULTS
We identified 1,955 patients using registry queries. BCVI was confirmed upon chart review in 1,215; of these, 69 were excluded due to death within 48 hours. The final cohort included 1,146 patients. The total number of blunt trauma patients captured in our trauma registry over the same time frame was 47,733, yielding a BCVI rate of 2.4%.
Patient Characteristics and Outcomes
Of 108 patients with any stroke, 15 were definitively due to causes other than BCVI and another 41 were present on arrival or detected within the first 24 hours, leaving 52 delayed strokes attributed to BCVI. Stroke was confirmed with MRI in 75% of the 108 patients with any stroke and in 71% of the 52 patients with delayed BCVI stroke; the remainder were diagnosed using longitudinal CT evaluation. There was no significant shift in diagnostic modality over the study duration (p = 0.914, linear regression). Table 1 tabulates demographic, injury, hospitalization, and outcome characteristics for patients with early stroke, delayed stroke, or no stroke. Ninety percent of all patients underwent at least one TCD examination, which was similar across injury grades. Antiplatelet or anticoagulant therapy was administered to 63.1% of patients who did not develop BCVI stroke and to 75.0% of patients who did develop delayed BCVI stroke. Patients with BCVI stroke had high mortality, with stroke directly causing or contributing to death in 77.8% and 76.5% of those whose events occurred before or after 24 hours, respectively.
Among patients without stroke, 74.2% had an isolated vascular injury compared with 48.1% of patients with delayed stroke. As shown in Table 2 , the risk of delayed BCVI stroke increased with the number of injured vessels.
ICA Injuries
Of 257 patients with isolated ICA injuries undergoing TCD examinations, nine had delayed BCVI stroke. Five of these nine patients (55.6%) had positive TCDs prior to stroke detection, compared with only 52 (18.5%) of the 248 without delayed BCVI stroke. Thus, patients with positive TCDs had a 5.05-fold increase in the likelihood of delayed stroke compared with those with negative TCDs (95% CI, 1.41-18.13). Table 3 shows the associations between TCDs and stroke stratified by ICA injury grade; all strokes following positive TCDs occurred in patients with grades 2-4 injuries.
The number of microemboli detected was also an important determinant of stroke risk. Among patients with isolated ICA injuries, stroke risk was 1.9% in patients without microemboli, 0% in patients with 1-6 MES/hr, 6.7% in patients with 7-40 MES/hr, and 40.0% in patients with greater than 40 MES/ hr (p = 0.001, Spearman correlation).
Adjusted analyses are shown in Table 4 ; after adjusting for injury grade, the observed trend persisted although the association between positive TCDs and stroke was no longer statistically significant. However, there was a significant association between the numbers of microemboli detected and stroke, with the risk of stroke increasing by 3% per MES/hr. We performed a secondary analysis to explore the generalizability of these estimates in patients with nonisolated ICA injuries. After adjustment for ipsilateral and contralateral ICA injury grade, patients with greater than or equal to one MES were nearly three times as likely to stroke (95% CI, 1.42-5.97), with the risk increasing by 1% per MES/hr (95% CI, 1.01-1.02).
We then examined the relationship between serial TCD results, medication use, and stroke in patients with isolated ICA injuries. As shown in Figure 1 , delayed stroke was more common in patients whose TCDs remained positive than in patients whose TCDs became negative (4/10 = 40% vs 1/40 = 2%; RR, 16.0; 95% CI, 2.00-127.93). However, escalation of medical therapy did not significantly affect TCD results or the risk of stroke. TCDs were just as likely to remain positive 
VA Injuries
Delayed BCVI stroke was observed in eight of 449 patients (1.8%) with isolated VA injuries who underwent TCD These analyses included patients with multiple vascular injuries. Poisson regression with robust CIs, adjusting for grade of the ipsilateral and contralateral carotid injuries (if present) and clustering at the level of the patient.
examinations (Table 3) . No patients with stroke had positive TCDs beforehand. Among patients with single or multiple injuries, two suffered delayed posterior circulation BCVI stroke following positive TCDs. However, positive microemboli were not more common in patients with delayed posterior circulation BCVI stroke than in patients without stroke (RR, 0.90; 95% CI, 0.21-3.83). Medical therapy did not clearly affect TCD results in patients with isolated VA injuries. In those with positive TCDs, continued microemboli were seen in one of eight (12.5%) patients whose medications were escalated, compared with 11 of 41 patients (23%) whose medications were not escalated (RR, 0.46; 95% CI, 0.07-3.12).
DISCUSSION
One thousand one hundred forty-six patients with 1,527 BCVIs were studied over the 123 months of this study, representing the largest BCVI cohort to date. Consistent with previous data, the frequency of BCVI-attributed stroke was 8.1% (1) (2) (3) (4) (5) . Although many strokes occurred early, 4.5% of our cohort had strokes that were detected greater than 24 hours after arrival and were therefore potentially preventable. Overall, 32.7% of patients with delayed BCVI stroke died, with stroke either causing or contributing to death in 77%; although this rate compares favorably with historic series (2, 25, 26) , it remains unacceptably high and highlights the importance of stroke prevention.
ICA Injuries
Our data demonstrate that TCD examinations may help providers identify patients at higher risk of stroke due to blunt ICA injuries. Emboli detection was a significant predictor of stroke in crude analyses and in most adjusted models despite the small number of delayed strokes in the dataset.
Ideally, detection of emboli should inform effective stroke prophylaxis. However, all patients sustaining stroke after positive TCDs did so despite up-titration of their medical therapy. Likewise, escalated medical management was not associated with normalization of TCD examinations. This finding is in contrast to the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) study of symptomatic carotid stenosis, which demonstrated that addition of clopidogrel to aspirin monotherapy led to a reduction in microembolic burden (27) . This discrepancy may be due to differences between asymptomatic acute BCVI and symptomatic chronic carotid stenosis and the nonrandom assignment of treatments in our cohort. Still, given the retrospective nature of this study, we cannot ascertain what patients' embolic burden or extent of stroke might have been in the absence of medical therapy, since this was targeted toward patients at the highest risk. Thus, the ability of TCDs to drive medical management and procedural interventions to prevent stroke therefore remains unclear; further prospective study is warranted to more clearly elucidate the effect of TCD-guided management on stroke prevention.
VA Injuries
We did not identify an association between the results of TCD examinations and subsequent BCVI-related posterior circulation stroke due to VA injuries, suggesting that TCDs are not useful in stratifying risk in these patients.
Commentary
We acknowledge several limitations to this study. Although it is the largest BCVI cohort to date, our primary outcome was rare. Therefore, we could include only a small number of predictor variables in multivariable models, which may not represent all factors influencing stroke risk. Additionally, we faced limitations regarding stroke ascertainment: identification of stroke timing requires recognition of subtle clinical changes, which were not always clearly documented in the medical record and which may have been obscured by concomitant brain injury, spinal cord injury, and mechanical ventilation with sedation. This limitation is confounded by the limited sensitivity of CT for acute stroke (28) ; strokes present at admission in patients with unreliable examinations may not be detected until follow-up imaging is obtained hours or even days later. Furthermore, stroke was identified using our institutional trauma registry. Although we expect good capture given the use of trained coders, stroke's significance as a quality metric, and the importance of capturing stroke for billing purposes, ascertainment may have been incomplete.
We also faced analytic limitations related to the nonrandom treatment of patients within our retrospective study. Decisions on medication administration may have been influenced by a host of other factors besides TCD results, including concomitant injuries (e.g., intracranial hemorrhage), comorbidities (e.g., venous thromboembolism), and anatomic features of the BCVI. It is therefore difficult to know with certainty whether medication changes were made in response to TCD examination Critical Care Medicine www.ccmjournal.org e1017 findings or other factors. Additionally, although all patients who experienced stroke after positive TCDs did so despite escalation in their care, it is impossible to know if these strokes would have been worse if the interventions had not been made.
Finally, although a brief monitoring duration was used to minimize clinical disturbance, the TCD literature suggests that longer monitoring durations can enhance the detection of microemboli in other scenarios (29) . Given these optimistic results with short-duration examinations, longer duration monitoring may further improve stroke risk discrimination.
CONCLUSIONS
In a large series of patients with BCVI, we found that TCD microemboli monitoring identified patients at higher risk of delayed BCVI stroke due to grade 2, 3, or 4 ICA injuries. However, our data do not support the use of TCD microemboli monitoring in patients with grade 1 ICA injuries or VA injuries of any grade. Further prospective study with randomized trials is warranted to determine if TCD-guided management can effectively prevent stroke due to higher grade blunt carotid injuries.
